Cargando…
Regenerative Therapies for Diabetic Microangiopathy
Hyperglycaemia occurring in diabetes is responsible for accelerated arterial remodeling and atherosclerosis, affecting the macro- and the microcirculatory system. Vessel injury is mainly related to deregulation of glucose homeostasis and insulin/insulin-precursors production, generation of advanced...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321284/ https://www.ncbi.nlm.nih.gov/pubmed/22536216 http://dx.doi.org/10.1155/2012/916560 |
_version_ | 1782228928022183936 |
---|---|
author | Bassi, Roberto Trevisani, Alessio Tezza, Sara Ben Nasr, Moufida Gatti, Francesca Vergani, Andrea Farina, Antonio Fiorina, Paolo |
author_facet | Bassi, Roberto Trevisani, Alessio Tezza, Sara Ben Nasr, Moufida Gatti, Francesca Vergani, Andrea Farina, Antonio Fiorina, Paolo |
author_sort | Bassi, Roberto |
collection | PubMed |
description | Hyperglycaemia occurring in diabetes is responsible for accelerated arterial remodeling and atherosclerosis, affecting the macro- and the microcirculatory system. Vessel injury is mainly related to deregulation of glucose homeostasis and insulin/insulin-precursors production, generation of advanced glycation end-products, reduction in nitric oxide synthesis, and oxidative and reductive stress. It occurs both at extracellular level with increased calcium and matrix proteins deposition and at intracellular level, with abnormalities of intracellular pathways and increased cell death. Peripheral arterial disease, coronary heart disease, and ischemic stroke are the main causes of morbidity/mortality in diabetic patients representing a major clinical and economic issue. Pharmacological therapies, administration of growth factors, and stem cellular strategies are the most effective approaches and will be discussed in depth in this comprehensive review covering the regenerative therapies of diabetic microangiopathy. |
format | Online Article Text |
id | pubmed-3321284 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-33212842012-04-25 Regenerative Therapies for Diabetic Microangiopathy Bassi, Roberto Trevisani, Alessio Tezza, Sara Ben Nasr, Moufida Gatti, Francesca Vergani, Andrea Farina, Antonio Fiorina, Paolo Exp Diabetes Res Review Article Hyperglycaemia occurring in diabetes is responsible for accelerated arterial remodeling and atherosclerosis, affecting the macro- and the microcirculatory system. Vessel injury is mainly related to deregulation of glucose homeostasis and insulin/insulin-precursors production, generation of advanced glycation end-products, reduction in nitric oxide synthesis, and oxidative and reductive stress. It occurs both at extracellular level with increased calcium and matrix proteins deposition and at intracellular level, with abnormalities of intracellular pathways and increased cell death. Peripheral arterial disease, coronary heart disease, and ischemic stroke are the main causes of morbidity/mortality in diabetic patients representing a major clinical and economic issue. Pharmacological therapies, administration of growth factors, and stem cellular strategies are the most effective approaches and will be discussed in depth in this comprehensive review covering the regenerative therapies of diabetic microangiopathy. Hindawi Publishing Corporation 2012 2012-03-29 /pmc/articles/PMC3321284/ /pubmed/22536216 http://dx.doi.org/10.1155/2012/916560 Text en Copyright © 2012 Roberto Bassi et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Bassi, Roberto Trevisani, Alessio Tezza, Sara Ben Nasr, Moufida Gatti, Francesca Vergani, Andrea Farina, Antonio Fiorina, Paolo Regenerative Therapies for Diabetic Microangiopathy |
title | Regenerative Therapies for Diabetic Microangiopathy |
title_full | Regenerative Therapies for Diabetic Microangiopathy |
title_fullStr | Regenerative Therapies for Diabetic Microangiopathy |
title_full_unstemmed | Regenerative Therapies for Diabetic Microangiopathy |
title_short | Regenerative Therapies for Diabetic Microangiopathy |
title_sort | regenerative therapies for diabetic microangiopathy |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321284/ https://www.ncbi.nlm.nih.gov/pubmed/22536216 http://dx.doi.org/10.1155/2012/916560 |
work_keys_str_mv | AT bassiroberto regenerativetherapiesfordiabeticmicroangiopathy AT trevisanialessio regenerativetherapiesfordiabeticmicroangiopathy AT tezzasara regenerativetherapiesfordiabeticmicroangiopathy AT bennasrmoufida regenerativetherapiesfordiabeticmicroangiopathy AT gattifrancesca regenerativetherapiesfordiabeticmicroangiopathy AT verganiandrea regenerativetherapiesfordiabeticmicroangiopathy AT farinaantonio regenerativetherapiesfordiabeticmicroangiopathy AT fiorinapaolo regenerativetherapiesfordiabeticmicroangiopathy |